| Literature DB >> 33214906 |
Camille Akemann1,2, Danielle N Meyer1,2, Katherine Gurdziel3, Tracie R Baker1,2.
Abstract
The legacy endocrine disrupting chemical and aryl hydrocarbon receptor agonist, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), is produced as a byproduct of industrial processes and causes adverse health effects ranging from skin irritation to cancer. TCDD endpoints are also observed in subsequent, unexposed generations; however, the mechanisms of these multi- and transgenerational effects are unknown. We hypothesized an epigenetic mechanism, specifically DNA methylation for the transgenerational, male-mediated reproductive effects of developmental TCDD exposure. Using whole genome bisulfite sequencing, we evaluated DNA methylation changes in three generations of zebrafish, the first of which was exposed to TCDD during sexual development at 50 ppt for 1 h at both 3- and 7-week post-fertilization. We discovered that TCDD induces multi- and transgenerational methylomic changes in testicular tissue from zebrafish with decreased reproductive capacity, but most significantly in the indirectly exposed F1 generation. In comparing differentially methylated genes to concurrent transcriptomic changes, we identified several genes and pathways through which transgenerational effects of low level TCDD exposure are likely inherited. These include significant differential methylation of genes involved in reproduction, endocrine function, xenobiotic metabolism, and epigenetic processing. Notably, a number of histone modification genes were both differentially methylated and expressed in all generations, and many differentially methylated genes overlapped between multiple generations. Collectively, our results suggest that DNA methylation is a promising mechanism to explain male-mediated transgenerational reproductive effects of TCDD exposure in zebrafish, and these effects are likely inherited through integration of multiple epigenetic pathways.Entities:
Keywords: 2,3,7,8-tetrachlorodibenzo-p-dioxin; epigenetics; methylation; reproduction; transgenerational; zebrafish
Year: 2020 PMID: 33214906 PMCID: PMC7660120 DOI: 10.1093/eep/dvaa010
Source DB: PubMed Journal: Environ Epigenet ISSN: 2058-5888
Figure 1:Volcano plot of significantly DMSs between F1 generation (A) and F2 generation (B) descendants of TCDD-treated and -untreated zebrafish testes depicting percent methylation change and P-value of methylated sites (circles). Significantly changed CpG sites (percent methylation change 5%; P-value ≤0.05) are in yellow
Figure 2:Distribution of significant (percent methylation change ≥5%; P-value ≤0.05) F1 generation (A) and F2 generation (B) DMSs relative to nearest gene. x-Axis represents location of DMS relative to nearest gene and y-axis represents number of sites at each location
Figure 3:Venn diagram of significantly differential methylated genes and overlap in F0, F1, and F2 generations (P-value <0.05)
Differentially methylated F1 genes involved in reproduction
| Gene symbol | Gene name | DMRs | DMSs |
|---|---|---|---|
| Reproduction | |||
| General | |||
| adcyap1r1aa,b | Adenylate cyclase activating polypeptide 1a (pituitary) receptor type I | 4 ↑ | 1 ↓ |
| cftr | CF transmembrane conductance regulator | 2 ↑ | 1 ↑ |
| csf1raa | Colony stimulating factor 1 receptor, a | 2 ↑, 1 ↓ | 1 ↓ |
| ptenb | Phosphatase and tensin homolog b | 2 ↑ | 0 |
| gata4 | GATA-binding protein 4 | 6 ↓ | 0 |
| fshr | Follicle stimulating hormone receptor | 2 ↑, 1 ↓ | 1 ↑, 2 ↓ |
| inhbaaa | Inhibin subunit beta Aa | 3 ↓ | 0 |
| inhbab | Inhibin subunit beta Ab | 4 ↑, 2 ↓ | 1 ↑ |
| inhbb | Inhibin subunit beta Bb | 2 ↑ | 0 |
| Sexual differentiation | |||
| zfpm2aa,b | Zinc finger protein, FOG family member 2a | 6 ↓ | 2 ↓ |
| zfpm2b | Zinc finger protein, FOG family member 2b | 3 ↑ | 0 |
| sox9aa,b | SRY-box transcription factor 9a | 1 ↑, 2 ↓ | 1 ↓ |
| sox9b | SRY-box transcription factor 9b | 1 ↑ | 0 |
| wnt4b | Wingless-type MMTV integration site family, member 4b | 2 ↓ | 0 |
| nr0b1 | Nuclear receptor subfamily 0, group B, member 1 | 1 ↓ | 1 ↓ |
| Spermatogenesis | |||
| dhx36 | DEAH (Asp-Glu-Ala-His) box polypeptide 36 | 2 ↑, 6 ↓ | 4 ↑, 8 ↓ |
| m1ap | Meiosis 1-associated protein | 1 ↑, 2 ↓ | 1 ↑, 1 ↓ |
| fmr1 | FMRP translational regulator 1 | 10 ↑, 22 ↓ | 12 ↑, 15 ↓ |
| brip1 | BRCA1 interacting protein C-terminal helicase 1 | 6 ↓ | 0 |
| cadm1aa,b | Cell adhesion molecule 1a | 9 ↑, 1 ↓ | 1 ↑ |
| cadm1b | Cell adhesion molecule 1b | 2 ↑ | 0 |
| dazl | Deleted in azoospermia-like | 2 ↓ | 0 |
| dzip1 | DAZ interacting zinc finger protein 1 | 2 ↑ | 0 |
| cx43 | Connexin 43 | 1 ↑, 1 ↓ | 0 |
| hook1 | Hook microtubule-tethering protein 1 | 2 ↑, 1 ↓ | 0 |
| hsf2 | Heat shock transcription factor 2 | 1 ↑, 1 ↓ | 0 |
| pdgfab | Platelet-derived growth factor alpha polypeptide b | 3 ↑ | 0 |
| piwil2 | Piwi-like RNA-mediated gene silencing 2 | 2 ↓ | 0 |
| sbf1 | SET-binding factor 1 | 2 ↑ | 0 |
| dnaja1 | DnaJ heat shock protein family (Hsp40) member A1 | 1 ↑, 2 ↓ | 0 |
| elavl1 | ELAV like RNA-binding protein 1 | 3 ↓ | 0 |
| jam3b | Junctional adhesion molecule 3b | 1 ↑, 3 ↓ | 0 |
| pacrg | PARK2 co-regulated | 4 ↓ | 0 |
| prlrb | Prolactin receptor b | 2 ↓ | 0 |
| gpx4b | Glutathione peroxidase 4b | 1 ↓ | 1 ↓ |
| psme4b | Proteasome activator subunit 4b | 1 ↑, 1 ↓ | 1 ↑ |
| cnr1 | Cannabinoid receptor 1 | 1 ↓ | 1 ↓ |
| rfx2 | Regulator factor X, 2 | 2 ↓ | 2 ↓ |
| brdt | Bromodomain, testis-specific | 4 ↑ | 0 |
| Sertoli cell junction | |||
| cldn11b | Claudin 11b | 4 ↑ | 0 |
| cldn7b | Claudin 7b | 2 ↓ | 0 |
| mtmr2 | Myotubularin-related protein 2 | 2 ↓ | 0 |
| myo7aaa | Myosin 7aa | 2 ↑ | 0 |
| tjp2aa | Tight junction protein 2a | 2 ↑, 2 ↓ | 0 |
| tjp2b | Tight junction protein 2b | 1 ↓ | 1 ↓ |
| itgb1aa | Integrin, beta 1a | 4 ↓ | 0 |
| limk1aa | LIM domain kinase 1a | 2 ↑ | 0 |
| tgfb2 | Transforming growth factor, beta 2 | 2 ↓ | 0 |
| klf6aa | Kruppel-like factor 6a | 5 ↑ | 0 |
Numbers of DMSs and regions are shown with direction of methylation change.
Gene is associated with a DMR.
Gene is associated with a DMS.
F1 IPA pathways related to male reproduction
| F1 male reproduction pathways | ||
|---|---|---|
| Disease/function |
| Number of genes |
| Genital tumor | 7.75E−17 | 589 |
| Genital tract cancer | 2.46E−16 | 578 |
| Tumorigenesis of reproductive tract | 4.25E−12 | 420 |
| Development of genital tumor | 6.63E−11 | 407 |
| Male genital neoplasm | 7.6E−11 | 360 |
| Malignant neoplasm of male genital organ | 2.44E−10 | 355 |
| Development of reproductive system | 5.27E−07 | 89 |
| Morphology of reproductive system | 1.44E−05 | 77 |
| Fertility | 1.41E−06 | 49 |
| Proliferation of Sertoli cells | 9.55E−06 | 6 |
| Production of sperm | 1.70E−05 | 6 |
F2 IPA pathways related to male reproduction
| F2 male reproductive pathways | ||
|---|---|---|
| Disease/function |
| Number of genes |
| Morphology of genital organ | 0.00043 | 5 |
| Abnormal morphology of internal genitalia | 0.000883 | 4 |
| Morphology of testis | 0.000951 | 4 |
| Development of reproductive system | 0.0143 | 4 |
| Mass of testis | 0.0017 | 3 |
| Abnormal morphology of testis | 0.00371 | 3 |
| Development of genital organ | 0.0324 | 3 |
| Morphology of vas deferens | 0.00177 | 2 |
| Concentration of testosterone | 0.00332 | 2 |
| Disorder of epididymis | 0.0036 | 2 |
| Cell death of male germ cells | 0.00687 | 2 |
| Development of internal genitalia | 0.034 | 2 |
| Lack of epididymis | 0.00453 | 1 |
| Elongation of spermatids | 0.00544 | 1 |
| Lack of vas deferens | 0.00634 | 1 |
| Abnormal morphology of enlarged testis | 0.00994 | 1 |
| Proliferation of spermatogonia | 0.0153 | 1 |
| Morphogenesis of male genital organ | 0.0171 | 1 |
| Cell death of spermatocytes | 0.0278 | 1 |
| Abnormal morphology of Sertoli cells | 0.034 | 1 |
| Atrophy of testis | 0.0392 | 1 |
| Sterility | 0.0392 | 1 |
| Mass of seminal vesicle | 0.0225 | 1 |
Genes both differentially methylated and differentially expressed in the F1 generation with roles in reproduction
| Gene | Methylation | Gene expression | Function | ||
|---|---|---|---|---|---|
| Percent change |
| Fold change |
| ||
| otud6b | −24.2 | 9.38E−03 | 1.23 | 2.43E−02 | Deubiquitinating enzyme; variants in this gene can cause Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features including cryptorchidism Santiago-Sim |
| −12.0 | 1.37E−06 | ||||
| −6.64 | 2.90E−03 | ||||
| dirc2 | −11.4 | 1.96E−02 | 1.23 | 4.32E−02 | Membrane-bound electrogenic metabolite transporter; increased expression in prostate cancer tissue [Nesslinger |
| −6.26 | 2.63E−03 | ||||
| plxna4 | −14.7 | 4.10E−05 | −1.2 | 2.58E−02 | Involved in axon guidance, axonal defasciculation, and morphogenesis of a branching structure; also found to be differentially methylated with BPA exposure in zebrafish [Olsvik |
| 62.0 | 1.06E−08 | ||||
| −9.25 | 6.45E−03 | ||||
| 22.8 | 8.52E−06 | ||||
| −10.4 | 4.71E−03 | ||||
| −10.4 | 4.71E−03 | ||||
| −6.19 | 2.86E−02 | ||||
| −5.69 | 4.62E−02 | ||||
| 58.4 | 2.68E−15 | ||||
| 58.4 | 2.68E−15 | ||||
| rhoub | 9.52 | 2.44E−03 | 1.31 | 4.38E−02 | Upstream regulator of the actin cytoskeleton through PAK1 and can initiate cell cycle reentry of quiescent cells; endometriosis (GWAS) |
| −10.3 | 6.46E−03 | ||||
| sall1aa,b | −22.9 | 3.40E−04 | 1.8 | 3.25E−02 | Positive regulation of fibroblast growth factor receptor signaling pathway, cryptorchidism, abnormal testis morphology (GWAS) |
| 11.7 | 3.44E−03 | ||||
| 11.7 | 3.44E−03 | ||||
| −9.76 | 2.21E−02 | ||||
| −9.76 | 2.21E−02 | ||||
| −6.40 | 1.24E−02 | ||||
| −6.32 | 7.73E−04 | ||||
| −5.81 | 1.85E−03 | ||||
| 6.61 | 3.69E−03 | ||||
| xpa | 7.90 | 2.20E−02 | −1.82 | 4.35E−02 | Nucleotide excision repair protein; decreased expression associated with defects in spermatogenesis Nakane |
| arrb1 | 13.6 | 1.71E−03 | 1.25 | 1.39E−02 |
Nucleotide excision repair protein; decreased expression associated with defects in spermatogenesis Nakane Cofactor in the beta-adrenergic receptor kinase-mediated desensitization of beta-adrenergic receptors; involved in FSH signaling pathway |
| 6.98 | 2.20E−02 | ||||
| acox1 | 17.9 | 2.40E−03 | 10.7 | 7.12E−03 | Fatty acid beta oxidation; necessary for fertility in mice Fan |
| 18.2 | 2.29E−02 | ||||
| 9.06 | 1.45E−03 | ||||
| −10.1 | 7.30E−05 | ||||
| −24.6 | 1.20E−03 | ||||
| 6.1 | 1.50E−02 | ||||
| −10.5 | 4.87E−06 | ||||
| −7.87 | 3.40E−03 | ||||
| ptenaa | 5.37 | 1.12E−02 | 1.17 | 3.19E−02 | Involved in gonadal development |
| 5.37 | 1.12E−02 | ||||
All DMSs and/or DMRs are listed.
Gene is associated with a DMR.
Gene is associated with a DMS.
All genes both differentially methylated and differentially expressed in the F2 generation
| Gene | Methylation | Gene expression | Function | ||
|---|---|---|---|---|---|
| Percent change |
| Fold change |
| ||
| si: dkey-266f7.5 | −11.3 | 2.09E−02 | 2.11 | 8.10E−03 | Unknown |
| snai3 | −7.69 | 4.76E−02 | −1.45 | 4.83E−02 | Roles in mesodermal formation during embryogenesis; involved in spermatogenesis |
| tmem132e | −17.2 | 2.28E−02 | −1.32 | 4.78E−02 | Required for normal inner ear hair cell function and hearing |
| pbx3bb | −18.1 | 2.50E−06 | 1.45 | 4.37E−02 | Transcriptional activator |
| −14.9 | 2.04E−06 | ||||
| −14.6 | 4.92E−03 | ||||
| 6.76 | 2.71E−02 | ||||
| capn7 | −25.3 | 1.68E−05 | −1.34 | 1.99E−02 | Member of the calpain family of proteins |
| −25.3 | 1.68E−05 | ||||
All DMSs and/or DMRs are listed.
Gene is associated with a DMS.
Gene is associated with a DMR.
Differentially expressed F1 and F2 genes involved in epigenetic processes
| Epigenetic role | F1 genes | F2 genes |
|---|---|---|
| Histone methyltransferase/demethylases and related genes |
|
|
| Other methylation-related genes |
|
|
| Histone acetyltransferase/deacetylases and related genes |
|
|
| Other epigenetic genes |
|
|
Fold changes and P-values of differentially expressed F1 and F2 genes involved in epigenetic processes
| Gene symbol | Gene name | Fold change |
|
|---|---|---|---|
| F1 genes | |||
| | Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E | −1.21 | 4.31E−02 |
| | Activating transcription factor 3 | 1.80 | 2.45E−03 |
| | Growth factor-independent 1B transcription repressor | 1.81 | 4.81E−02 |
| | Homeobox A10b | −1.33 | 2.34E−02 |
| | INO80 complex subunit C | −1.26 | 3.39E−02 |
| | Insulinoma-associated 1b | 1.22 | 5.57E−03 |
| | Jade family PHD finger 2 | 1.29 | 8.97E−03 |
| | Lysine (K)-specific demethylase 6B, b | 1.61 | 3.99E−02 |
| | L3MBTL histone methyl-lysine-binding protein 2 | −1.37 | 2.83E−02 |
| | Lysyl oxidase-like 2a | 2.26 | 1.10E−02 |
| | MAP/microtubule affinity-regulating kinase 3a | −1.60 | 3.17E−02 |
| | Methionine adenosyltransferase II, beta | −1.53 | 3.16E−02 |
| | Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like | −2.10 | 9.39E−03 |
| | 5-Methyltetrahydrofolate-homocysteine methyltransferase reductase | −1.42 | 1.93E−02 |
| | Nemo-like kinase, type 2 | 1.24 | 3.17E−02 |
| | PR domain containing 6 | 1.28 | 6.04E−03 |
| | Spalt-like transcription factor 1a | 1.80 | 3.25E−02 |
| | SWI/SNF related, matrix associated, actin-dependent regulator of chromatin, subfamily a, member 4a | −1.39 | 2.99E−02 |
| | SWI/SNF related, matrix associated, actin-dependent regulator of chromatin, subfamily c, member 1b | −1.79 | 3.49E−02 |
| | SET and MYND domain containing 1a | −3.60 | 6.41E−03 |
| | SPT7 like, STAGA complex subunit gamma | −1.39 | 3.75E−02 |
| | Ubiquitin-conjugating enzyme E2A (RAD6 homolog) | −1.47 | 2.78E−02 |
| | Ubiquitin-specific peptidase 49 | −1.49 | 4.90E−02 |
| | VRK serine/threonine kinase 1 | 1.23 | 4.12E−02 |
| | Zinc finger and BTB domain containing 38 | 1.32 | 4.08E−02 |
| F2 genes | |||
| | Actin-related protein 5 | −1.45 | 2.29E−02 |
| | AT rich interactive domain 1Ab (SWI-like) | −1.23 | 3.33E−02 |
| | Activator of transcription and developmental regulator AUTS2 a | −1.22 | 1.08E−02 |
| | BRMS1 like transcriptional repressor a | −2.57 | 2.57E−02 |
| | Histone deacetylase 10 | 1.29 | 3.38E−02 |
| | JUN dimerization protein 2b | −1.20 | 1.35E−02 |
| | Lysine (K)-specific methyltransferase 2D | −1.30 | 2.02E−02 |
| | Lysine methyltransferase 5Aa | −1.21 | 2.90E−02 |
| | Methyl-CpG-binding domain protein 2 | 1.26 | 2.65E−02 |
| | Methyl-CpG-binding domain protein 5 | −1.33 | 2.79E−02 |
| | Multiple endocrine neoplasia I | −1.20 | 2.87E−03 |
| | Polyhomeotic homolog 2b (Drosophila) | −1.37 | 1.81E−03 |
| | PHD finger protein 21Ab | −1.27 | 3.41E−02 |
| | RuvB-like AAA ATPase 1 | 1.29 | 8.25E−03 |
| | SET domain containing 5 | −1.32 | 2.09E−04 |
| | Splicing factor 3b, subunit 3 | 1.20 | 2.20E−02 |
| | SET and MYND domain containing 1b | −1.53 | 1.39E−02 |
| | SET and MYND domain containing 2b | −1.25 | 3.17E−02 |
| | WD repeat domain 61 | 1.3 | 1.96E−03 |
Differentially methylated F1 genes involved in the endocrine system, drug metabolism, histone modifications, or DNA methylation
| Gene symbol | Gene name | DMRs | DMSs |
|---|---|---|---|
| Endocrine | |||
| esr1 | Estrogen receptor 1 | 1 ↓ | 1 ↓ |
| esr2a | Estrogen receptor2a | 2 ↓ | 0 |
| esr2bb | Estrogen receptor 2b | 5 ↓ | 0 |
| hsd17b10 | Hydroxysteroid (17-beta) dehydrogenase 10 | 1 ↑, 3 ↓ | 1 ↑, 1 ↓ |
| mdm2 | MDM2 proto-oncogene | 4 ↓ | 2 ↓ |
| nr5a2 | Nuclear receptor subfamily 5, group A, member 2 | 4 ↑, 5 ↓ | 0 |
| ncoa4 | Nuclear receptor coactivator 4 | 3 ↑, 1 ↓ | 1 ↑ |
| Xenobiotic metabolism | |||
| ahr1a | Aryl hydrocarbon receptor 1a | 2 ↑ | 0 |
| ahr1b | Aryl hydrocarbon receptor 1b | 1 ↑, 2 ↓ | 2 ↓ |
| ahr2 | Aryl hydrocarbon receptor 2 | 1 ↑, 6 ↓ | 3 ↑, 2 ↓ |
| Histone modification | |||
| setd7 | SET domain containing 7, histone lysine methyltransferase | 1 ↑ | 1 ↑ |
| jak2a | Janus kinase 2a | 3 ↑ | 0 |
| jak2b | Janus kinase 2b | 0 | 1 ↑ |
| rbl1 | Retinoblastoma-like 1 | 1 ↑, 2 ↓ | 2 ↑ |
| rcor1 | REST corepressor 1 | 3 ↓ | 1 ↓ |
| taf6l | TAF6-like RNA polymerase II | 0 | 2 ↑ |
| mrgbp | MRG/MORF4L-binding protein | 4 ↑, 6 ↓ | 2 ↑ |
| brpf1 | Bromodomain and PHD finger containing, 1 | 2 ↑, 3 ↓ | 0 |
| carm1 | Coactivator-associated arginine methyltransferase 1 | 2 ↓ | 0 |
| ehmt2 | Euchromatic histone-lysine | 2 ↓ | 0 |
| hmga2 | High mobility group AT-hook 2 | 1 ↓ | 0 |
| kdm5bbb | Lysine (K)-specific demethylase 5Bb | 2 ↓ | 0 |
| ncor1 | Nuclear receptor corepressor 1 | 2 ↑ | 0 |
| ncor2 | Nuclear receptor corepressor 2 | 2 ↑, 2 ↓ | 0 |
| pak2bb | p21 protein (Cdc42/Rac)-activated kinase 2b | 2 ↓ | 0 |
| phc2aa | Polyhomeotic homolog 2a | 2 ↓ | 1 ↑, 1 ↓ |
| prkcbbb | Protein kinase C beta b | 2 ↓ | 0 |
| raraa | Retinoic acid receptor, alpha a | 2 ↑ | 0 |
| rarabb | Retinoic acid receptor, alpha b | 1 ↑, 3 ↓ | 0 |
| psme4b | Proteasome activator subunit 4b | 1 ↑, 1 ↓ | 1 ↑ |
| cnr1 | Cannabinoid receptor 1 | 1 ↓ | 1 ↓ |
| rfx2 | Regulatory factor X, 2 | 2 ↓ | 2 ↓ |
| alkbh1 | AlkB homolog 1, histone H2A dioxygenase | 0 | 2 ↑, 2 ↓ |
| DNA methylation | |||
| dnmt3aa | DNA (cytosine-5-)-methyltransferase 3 alpha a | 1 ↑ | 0 |
| dnmt3abb | DNA (cytosine-5-)-methyltransferase 3 alpha b | 2 ↓ | 0 |
| dnmt3ba | DNA (cytosine-5-)-methyltransferase 3 beta a | 1 ↓ | 1 ↑ |
| ppm1db | Protein phosphatase, Mg2+/Mn2+ dependent, 1Db | 2 ↑ | 1 ↑ |
Numbers of DMSs and regions are shown with direction of methylation change.
Gene is associated with a DMS.
Gene is associated with a DMR.
Differentially methylated F2 genes involved in reproduction, the endocrine system, and epigenetic processes
| Gene symbol | Gene name | DMRs | DMSs |
|---|---|---|---|
| Reproduction | |||
| wnt9b | Wingless-type MMTV integration site family, member 9B | 0 | 2 ↑ |
| elavl1 | ELAV like RNA-binding protein 1a | 0 | 1 ↓ |
| mycbp | MYC-binding protein | 0 | 2 ↑ |
| rab11bb | RAB11B, member RAS oncogene family, b | 0 | 1 ↑ |
| fmr1 | FMRP translational regulator 1 | 1 ↑, 11 ↓ | 1 ↑, 2 ↓ |
| stoml2 | Stomatin (EPB72)-like 2 | 3 ↑, 7 ↓ | 2 ↑, 1 ↓ |
| nf2bb | Neurofibromin 2b | 2 ↓ | 0 |
| otx2 | Orthodenticle homeobox 2 | 1 ↓ | 0 |
| Endocrine | |||
| nr1h3 | Nuclear receptor subfamily 1, group H, member 3 | 0 | 2 ↓ |
| nr5a2 | Nuclear receptor subfamily 5, group A, member 2 | 1 ↓ | 2 ↑, 2 ↓ |
| Epigenetic | |||
| mrgbp | MRG/MORF4L-binding protein | 6 ↓ | 2 ↑, 4 ↓ |
Numbers of DMSs and regions are shown with direction of methylation change.
Gene is associated with a DMS.
Gene is associated with a DMR.